Press release
Inhalation CDMO Market Exclusive Report on Current Trends and Future Insights
According to the latest research by InsightAce Analytic, the Global Inhalation CDMO Market is valued at US$ 7.9 Bn in 2023, and it is expected to reach US$ 11.8 Bn by 2031, with a CAGR of 5.2% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2708
Inhalation Contract Development and Manufacturing Organizations (CDMOs) are specialized entities that provide end-to-end services for the development and production of inhalation-based pharmaceutical products. These services encompass the full product lifecycle, including formulation development, process optimization, scale-up, and commercial manufacturing. The inhalation CDMO market is experiencing significant growth, driven by the increasing prevalence of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and COVID-19, along with rising demand for advanced inhalation therapies.
Pharmaceutical companies are increasingly outsourcing to CDMOs to leverage their expertise in inhaled drug delivery, enabling faster development timelines, cost efficiencies, and improved product innovation. The surge in demand for targeted, effective respiratory treatments-combined with continuous advancements in inhalation drug delivery technologies-continues to propel market expansion. Nonetheless, the high cost associated with inhalation CDMO services remains a critical challenge, particularly for smaller enterprises seeking market entry or scaling opportunities.
List of Prominent Players in the Inhalation CDMO Market:
• Recipharm AB
• AptarGroup Inc.
• Hovione
• Vectura Group Ltd
• Nemera
• Kindeva
• H&T Presspart
• Sanner GmbH
• Stevanato Group
• Medspray
• ICONOVO AB
• Lonza
• Gerresheimer AG
• Catalent
• Thermo Fisher Scientific Inc.
• Lubrizol Life Science
• Enteris BioPharma
• Cambrex Corporation
• INKE
• Piramal Pharma Limited
• Lupin
• Others
Market Dynamics
Drivers:
The increasing demand for inhalation CDMO services is primarily attributed to the growing incidence of respiratory disorders, including asthma and cystic fibrosis. This rise in respiratory conditions has intensified the need for advanced and effective inhalation therapies. In response, pharmaceutical companies are increasingly seeking specialized partners with expertise in the formulation and manufacturing of inhalation-based drug products. Technological advancements in drug delivery systems-such as dry powder inhalers (DPIs) and metered-dose inhalers (MDIs)-further reinforce this demand, as these devices require high-precision development and production capabilities.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2708
Challenges:
Despite promising growth prospects, the inhalation CDMO market faces several challenges. High development and production costs, complex formulation processes, and stringent regulatory frameworks are among the primary obstacles. The need for specialized infrastructure and technical expertise increases operational expenditures, potentially limiting entry for smaller or emerging firms.
Regional Trends:
North America is anticipated to command a leading share of the inhalation CDMO market, with strong revenue performance and a high projected compound annual growth rate (CAGR). This growth is underpinned by a well-established pharmaceutical and biotechnology industry, robust investment in respiratory drug development, and favorable regulatory support. In parallel, Europe represents a major contributor to global market share, supported by its advanced manufacturing infrastructure, skilled workforce, and commitment to technological innovation. The region's strategic emphasis on efficient, high quality inhalation product development reinforces its competitive position in the global market.
Recent Developments:
• In May 2024, ReciBioPharm, a business unit of Recipharm that develops new and advanced therapies, announced a partnership with GeneVentiv Therapeutics, a preclinical gene therapy company. The two will collaborate to develop an AAV-based universal gene therapy for hemophilia, which will be the first treatment for hemophilia patients with inhibitors.
• In June 2024, Aptar Digital Health, a frontrunner in the field of digital health solutions, connected devices, and disease management, announced a partnership with SHL Medical, a frontrunner in the field of advanced medication delivery systems (including autoinjectors, pen injectors, and specialized delivery systems), today. To further assist patients undergoing injectable treatment in managing their condition, the partnership will expand SHL Medical's linked device technologies by including Aptar Digital Health's SaMD platform.
Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/2708
Segmentation of Inhalation CDMO Market-
Inhalation CDMO Market- By Service
• Formulation Development
• Device Development and Manufacturing
• Clinical Manufacturing
• Scale-up and Tech Transfer
• Quality Control and Quality Assurance
• Technology and Innovation
• Regulatory Assistance
• Analytical Services
Inhalation CDMO Market- By Application
• API
o API Substrate
o Large Molecule
o Small Molecule
• Inhalation Platform
o API Substrate
o Large Molecule
o Small Molecule
Inhalation CDMO Market- By Company Size
• Large
• Medium
• Small
Inhalation CDMO Market- By Scale of Operation
• Preclinical
• Clinical
• Commercial
Inhalation CDMO Market- By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Get More Information :
https://www.insightaceanalytic.com/report/inhalation-cdmo-market/2708
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inhalation CDMO Market Exclusive Report on Current Trends and Future Insights here
News-ID: 4158302 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Inhaler Corticosteroid Device Market Growth and Restrain Factors Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Inhaler Corticosteroid Device Market- (By Steroid Types (Beclomethasone Dipropionate, Budesonide, Fluticasone Inhaler Powder, & Mometasone), By Application (Asthma, COPD (Chronic Obstructive Pulmonary Disease) and Others) By End-user (Hospitals and Clinics, Academic and Research Institutes and Respiratory Care Center)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the…
Inhalable Biologics Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Health Coaching Market - By Type (Peptides And Proteins, Vaccines, Monoclonal Antibodies, RNAi-Based Therapeutics), Application (Respiratory Diseases, Diabetes, Cancer), Dosage Form (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), And Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies), Trends, Industry Competition Analysis, Revenue And Forecast To 2034."
The global inhalable biologics market is estimated to…
Chlorphenamine Maleate API Market Report- Expansive Coverage on the Profit Sourc …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Chlorphenamine Maleate API Market - (by Type (Purity :No Higher Than 98%, Purity :Higher Than 98%) by Application (Tablets, Injection)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Chlorphenamine Maleate API Market is valued at US$ 70.2 Mn in 2023, and it is expected to…
MedTech CMO Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global MedTech CMO Market Size, Share & Trends Analysis Report By Product and Services (Design, Manufacturing, Sterilization and Packaging, Others), Manufacturing Techniques (Injection Molding, Cutting and Machining, Extrusion, Blow Molding, Others), End-users (Drug Delivery Devices, Orthopedics, MIS, Surgical Instruments, IVD, Electromechanical, Medical Equipment, Others)- Market Outlook And Industry Analysis 2031"
The Global MedTech CMO Market is expected…
More Releases for CDMO
Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract…
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Inhalation CDMO Market Size During the Forecast Period?
In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024…
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size?
The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of…
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To…
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest…
Peptide CDMO Market Size 2024 to 2031.
Market Overview and Report Coverage
A Peptide CDMO (Contract Development and Manufacturing Organization) is a company that provides services for the development and manufacturing of peptides, which are short chains of amino acids used in various pharmaceutical and biotechnological applications.
The future outlook of the Peptide CDMO Market looks promising, with a projected growth rate of 15.10% during the forecasted period. This growth is fueled by the increasing demand for…
